Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCO cytochrome oxidase deficient homolog 1 pseudogene (ENSG00000258051) is classified as a pseudogene in the human genome[1][5]. Unlike its functional parent gene, SCO1, which participates in mitochondrial cytochrome c oxidase assembly, this pseudogene does not encode a functional protein and is not involved as a biological receptor, enzyme, or therapeutic target. Pseudogenes result from gene duplication or retrotransposition followed by loss of function, possibly retaining some regulatory RNA activity, but no direct evidence supports any disease association or functional relevance for ENSG00000258051 specifically[1][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCO cytochrome oxidase deficient homolog 1 pseudogene.